chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. In April 2017, the patients were vaccinated with improperly stored doses of PNEUMOVAX23 (lot #, expiration date, dose and route of administration were not reported) for prophylaxis. No adverse effects were reported. Administered doses of vaccines experienced the temperature excursion of 32 to 35 degrees Fahrenheit for 48 hours. Data logger was not involved. There were no previous excursions reported. Additional information has been requested.
I had symptoms (body aches and pains like I expected), 24-hours after my second Moderna shot. I received my first shot on 3/18/2021 and second shot 4/15/2021. My right arm and hand started throbbing. It seemed like the blood flow quit. The fingers on my hands are numb. "Pins and needles" feeling on my tips right now. The pain subsided in both arms. My right was worse than my left. But now the middle and ring fingers on both hands are completely numb and tingling. I would like to know if anyone else has had this problem and how long did it last?
Patient received her flu vaccine, without preservative, at 8am on 9/18/17. Patient reported that on 9/18/17, around 2pm she had a sudden onset of symptoms and experienced an episode of nausea, lightheadedness, and felt like she was going to pass out. Another episode occurred around 4:30-5pm when patient was standing and actually felt like she blacked out shortly. These episodes continued throughout the rest of the afternoon, around every 20 minutes. When patient went to her car to drive home, she realized that she should not drive home and called her husband, who came and picked her up. Patient reports that she is feeling fine as of 9/19/17.
had both shots, still got shingles/suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were provided as follows: The reporter was patient. The age at vaccination was not reported. The patient got both shots of shingles vaccine still experienced mild shingles. This case was considered as suspected vaccination failure since the details regarding time to onset and laboratory confirmation of shingles were not provided.
delirious dreams; extreme chills; so cold that it felt like burning ice cubes on skin, could not get warm even with multiple blankets; severe body aches; severe headache; fever of 101; nausea; thirsty; Symptoms began to abate today (almost 48 hours later) but still fet some foggy thinking; This is a spontaneous report from a contactable other health care professional (patient) and a contactable consumer.  A 63-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: ELIZ83), via an unspecified route of administration at arm left on 19Jan2021 at single dose for COVID-19 immunization. The patient medical history included hypothyroidism from an unknown date and unknown if ongoing. The patient concomitant medications were not reported. The patient previously received fist dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EH9899) via an unspecified route of administration at arm left on 29Dec2020 at 9:30 at single dose for COVID-19 immunization.   On Jan2021, the patient reported that 15 hours after second dose, he experienced extreme chills, so cold that it felt like burning ice cubes on his skin, he couldn't get warm even with multiple blankets, severe body aches, fever of 101 F, severe headache, delirious dreams, nausea, thirsty and feel some foggy thinking. The patient outcome of the event was recovering.
feels like I'm sweating right now; a little bit clammy; yucky; a bit tired; had a fever; really bad headache; arm got quite sore for about a day and a half; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (arm got quite sore for about a day and a half), HYPERHIDROSIS (feels like I'm sweating right now), COLD SWEAT (a little bit clammy), ILLNESS (yucky) and FATIGUE (a bit tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Aug-2021, the patient experienced VACCINATION SITE PAIN (arm got quite sore for about a day and a half). On 20-Aug-2021, the patient experienced HYPERHIDROSIS (feels like I'm sweating right now), COLD SWEAT (a little bit clammy), ILLNESS (yucky), FATIGUE (a bit tired), PYREXIA (had a fever) and HEADACHE (really bad headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse reaction, at an unspecified dose and frequency. On 18-Aug-2021, VACCINATION SITE PAIN (arm got quite sore for about a day and a half) had resolved. At the time of the report, HYPERHIDROSIS (feels like I'm sweating right now), COLD SWEAT (a little bit clammy), ILLNESS (yucky), FATIGUE (a bit tired), PYREXIA (had a fever) and HEADACHE (really bad headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications provided.  Patient does not have a spleen.
Child broke out in a rash 2 days after receiving 1 year immunizations.  The rash was on the trunk and back of her head.  The rash appeared to be raised with a white pus like head. It resembled baby acne. The vesical lasted about 1 day and did not scab over.  New vesicals appeared for about 1 week.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 08Jun2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Oxycodone, reaction(s): "Known allergies: oxycodone", notes: Known allergies: oxycodone, fentanyl; Fentanyl, reaction(s): "Known allergies: fentanyl", notes: Known allergies: oxycodone, fentanyl. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical Course: It was reported that vaccine was received. Other medication in 2 weeks was unknown. Other medical history was none. Antiviral details was Product: COVID 19 Treatment, Brand was Paxlovid, treatment start date was 12Aug2022 and Treatment stop date was 17Aug2022, Lot number was ge4607, Indication was Treatment of COVID-19. Rebound symptoms on day 7 post Paxlovid. Never tested positive when started Paxlovid on day 2 of symptoms but the same as family member who did test positive for COVID three days earlier.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.
DO;    Date of Admission:  2/13/2022   Chief Complaint:  Nausea, vomiting, and diarrhea   Source of Information:  Patient and Available medical record   History of Present Illness:  This is a 67y.o. female with a medical history of uterine cancer on chemotherapy at Facility, PE on Eliquis, HTN who presented to the ED for nausea, emesis, and diarrhea for 3 days prior to presentation. The patient is AOx3 but a poor historian and unable to provide any further therapy. She states that she not been feeling well and has had diarrhea and nausea. She denies any other issues.    ROS:  Constitutional:  Denies fever or chills  Eyes:  Denies change in visual acuity, eye pain  HENT:  Denies nasal congestion or sore throat  Respiratory:  Denies cough or shortness of breath  Cardiovascular:  Denies chest pain or edema  GI:  Admits to abdominal pain, nausea, vomiting, and diarrhea  GU:  Denies dysuria, hematuria   Musculoskeletal:  Denies back pain or joint pain  Integument:  Denies rash, papules Neurologic:  Denies headache, focal weakness or sensory changes  Endocrine:  Denies polyuria or polydipsia  Lymphatic:  Denies tender or enlarged lymph nodes  Psychiatric:  Denies depression or anxiety
diarrhea; fever; Doesn't feel good; he is so sick; vomiting; Headache; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PYREXIA (fever), MALAISE (Doesn't feel good), ILLNESS (he is so sick) and VOMITING (vomiting) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced DIARRHOEA (diarrhea), PYREXIA (fever), MALAISE (Doesn't feel good), ILLNESS (he is so sick), VOMITING (vomiting) and HEADACHE (Headache). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (diarrhea), PYREXIA (fever), MALAISE (Doesn't feel good), ILLNESS (he is so sick), VOMITING (vomiting) and HEADACHE (Headache) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  Treatment medication details included Aleve (naproxen).
Patient was given immunization and started bleeding heavily at site of injection and then instantly had a welt-like swollen area under injection. When I assessed the area prior to immunization, I did not feel a bump or hardened area at the site and patient was unaware of there being anything on her arm before the injection. After 1 hour the swelling did decrease but still had a small swollen area almost like an insect bite. Patient stopped bleeding within a few minutes.
This case was reported by a healthcare professional and described the occurrence of frozen shoulder in a subject of unspecified age and gender who was vaccinated with Influenza vaccine, (manufacturer unspecified).  On an unspecified date, the subject received a dose of Influenza vaccine (injection, unknown).  At an unspecified time after vaccination with Influenza vaccine, the subject experienced frozen shoulder.  At the time of reporting the outcome of the event was unspecified.  The orthopedist reported two other cases of frozen shoulder following influenza vaccine.  Additional cases see A0761235A and A0761289A.
48 hours post shot had a Supraventricular Tachycardia event and  acute Pulmonary Embolism was discovered while in the hospital. IV Blood thinners administered and then put on metoprolol and apixaban (for life)
Approximately 1 day after my 2nd dose vaccination I experienced the following symptoms: Chills, Loss of appetite, Body aches (extreme pain) I was not able to take any medication because it was hard to move around. Symptoms lasted for about 3-4 days and during the 5th day the symptoms got better but I started developing pain in my head. I went to the doctor for consultation and she had me take off work for 1 week to recover, the doctor said I have some kind of muscle spasm. She prescribed me to take ibuprofen. It did not help my condition. She also prescribed me with omeprazole and this one worked.
Fainted twice; Soreness of right arm; Sweating; Feeling chills; This spontaneous case was reported by a consumer and describes the occurrence of SYNCOPE (Fainted twice) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030B21A and 029A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history was reported.). Concomitant products included THYROID for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Mar-2021, the patient experienced SYNCOPE (Fainted twice) (seriousness criterion medically significant), PAIN IN EXTREMITY (Soreness of right arm), HYPERHIDROSIS (Sweating) and CHILLS (Feeling chills). At the time of the report, SYNCOPE (Fainted twice), PAIN IN EXTREMITY (Soreness of right arm), HYPERHIDROSIS (Sweating) and CHILLS (Feeling chills) outcome was unknown.            Treatment for the event included acetaminophen.  Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Very unusually heavy period; painful lymph nodes in armpit and under arm of right side where shot was administered; painful lymph nodes in armpit and under arm of right side where shot was administered; This is a spontaneous report from a non-contactable other hcp (patient). A 40-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on an unspecified date (Lot Number: Unknown) as 1ST DOSE, SINGLE for covid-19 immunisation. Pregnant at the time of vaccination was No. No known allergies. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Medical history was none. The patient's concomitant medications were not reported. After 1st shot, the patient experienced painful lymph nodes in armpit and under arm of right side where shot was administered. This pain started 5 days post vaccine and lasted 3 weeks! The patient also experienced very unusually heavy period as well. The adverse events resulted Doctor or other healthcare professional office/clinic visit. Treatment received for the adverse events included Advil, counseling. The outcome of events "painful lymph nodes in armpit and under arm of right side where shot was administered" was not recovered, the other event was unknown. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The events were reported as non-serious.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fever x 1 week. Achy, unwell feeling. Site reaction - softball sized red area egg sized lump.
Reporting MD indicated that one of pts did not sero-convert p/receiving Engerix-B; vax was administered approx 1 yr ago & 6mo later it was found that the pt had not sero converted;
t103 ax given APAP & cool bath then t98.8 ax; given APAP as precautionary measure; 1155-t100 ax given 1200 grand mal sz, pale, tonic clonic activity in all extremities, eyes fixed & rolled up into head, facial paralysis; pupils fixed;
Patient called and reported that the injection site got infected and she was taken to the hospital by ambulance. She was still hospitalized when she called to report the adverse reaction.
Woke up at 4:45 am and took a shower and felt very tired. Felt nauseated and dizzyness while sitting at 6:00 am, and had to lay down flat, Thought I was going to vomit. Had severe chills helped by going back to bed with a heated bed for an hour. Later by mid morning fever started, very flush in the face and by noon 100 degree fever that lasted for hours until early evening. Had headaches, body aches, aches around my heart (similar to being stressed) and sore arm as well that 2nd day. Headaches gradually went away after third day.
pt recv vax 6MAR97 & 16MAR97 pt exp a cont temp of 100.9 which lasted 2mo & pt recovered;
pt recv vax & devel an inj site rxn, characterized by redness, swelling, & pain;pt also exp knots & elevated temp around inj site;sx lasted for 1wk;this is one of six pt from this site to report adverse rxn;
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001321A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 12-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications reported by reporter No treatment medications provided by the reporter.     This case was linked to MOD-2021-435282 (Patient Link).
Hurt, all night long, my left arm throbbed; It was hot; so sick; Chest Hurt; Headache, head was throbbing; Completely wiped out; Getting sick to my stomach; Dizzy, Got the shakes; Felt strange; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Oct-2021 and was forwarded to Moderna on 27-Oct-2021.    This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Felt strange), PAIN (Hurt, all night long, my left arm throbbed), VACCINATION SITE WARMTH (It was hot), ABDOMINAL DISCOMFORT (Getting sick to my stomach) and DIZZINESS (Dizzy, Got the shakes) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 939904, 013M20A and 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Oct-2021, the patient experienced FEELING ABNORMAL (Felt strange). On 26-Oct-2021, the patient experienced ABDOMINAL DISCOMFORT (Getting sick to my stomach) and DIZZINESS (Dizzy, Got the shakes). On an unknown date, the patient experienced PAIN (Hurt, all night long, my left arm throbbed), VACCINATION SITE WARMTH (It was hot), ILLNESS (so sick), CHEST PAIN (Chest Hurt), HEADACHE (Headache, head was throbbing) and FATIGUE (Completely wiped out). At the time of the report, FEELING ABNORMAL (Felt strange), PAIN (Hurt, all night long, my left arm throbbed), VACCINATION SITE WARMTH (It was hot), ABDOMINAL DISCOMFORT (Getting sick to my stomach), DIZZINESS (Dizzy, Got the shakes), ILLNESS (so sick), CHEST PAIN (Chest Hurt), HEADACHE (Headache, head was throbbing) and FATIGUE (Completely wiped out) outcome was unknown.            No Treatment medication reported. No Concomitant medication reported.   This case was linked to MOD-2021-366180 (Patient Link).
Temperature 100.5-102. Swelling of all Lymph nods throughout entire body within 48 hours. EXTREME pain with swelling. 72 hours into time left side of body was swollen to point that clothing and jewelry do not fit. Left under arm and Breast are extra swollen *approximately triple size of right side. Migraine at 30 hours. Stomach pain in right side at 28 hours, also nausea and diarrhea.
Saturday  01/30/2021 lost peripheral vision. Went to hospital  Was given  Mri and ultra sound of head and neck stayed until sunday afternoon. Slept Sunday night  Now have not been able to sleep at night at  all since
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown gender and age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 18-APR-2013, the patient was inoculated with ZOSTAVAX by a healthcare provider as recommended for permanent prevention and protection against shingles and zoster-related conditions (dose, route, and lot # not provided). On an unknown date, the patient was diagnosed with shingles and/or zoster related injuries after and despite being inoculated with ZOSTAVAX vaccine and suffered serious mental and physical pain and suffering and required extensive medical care and treatment. On or about 14-DEC-2016, the patient was treated by a healthcare provider for shingles. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other medical related expenses which includes but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to an unspecified number of patients (demographics unknown). Pertinent medical history, drug reactions or allergies were not reported. On unknown dates, the patients were vaccinated with ZOSTAVAX (dose, lot and route were not reported) which was improperly stored outside the temperature stated in the prescribing information. No adverse reactions reported. This is one of multiple cases from the same reporter. Additional information is not expected.